A

Algernon Pharmaceuticals Inc
CNSX:AGN

Watchlist Manager
Algernon Pharmaceuticals Inc
CNSX:AGN
Watchlist
Price: 0.04 CAD Market Closed
Market Cap: CA$1.9m

Cash Flow Statement

Cash Flow Statement
Algernon Pharmaceuticals Inc

Rotate your device to view
Cash Flow Statement
Currency: CAD
Aug-2017 Nov-2017 Feb-2018 May-2018 Aug-2018 Nov-2018 Feb-2019 May-2019 Aug-2019 Nov-2019 Feb-2020 May-2020 Aug-2020 Nov-2020 Feb-2021 May-2021 Aug-2021 Nov-2021 Feb-2022 May-2022 Aug-2022 Nov-2022 Feb-2023 May-2023 Aug-2023 Nov-2023 Feb-2024 May-2024 Aug-2024 Nov-2024 Feb-2025 May-2025 Aug-2025 Nov-2025
Operating Cash Flow
Net Income
(2)
(2)
(1)
(1)
(1)
(1)
(2)
(2)
(2)
(2)
(2)
(6)
(9)
(12)
(13)
(10)
(8)
(6)
(5)
(4)
(6)
(7)
(6)
(6)
0
(5)
(5)
(3)
(1)
(0)
0
(2)
(2)
(2)
Depreciation & Amortization
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Stock-Based Compensation
0
0
0
0
0
0
0
0
0
0
0
2
3
4
4
2
1
0
0
0
1
1
1
1
1
1
0
0
0
0
0
0
0
0
Other Non-Cash Items
1
1
1
0
0
0
0
0
(0)
0
0
2
3
3
3
2
1
0
0
(0)
1
1
1
1
3
2
2
0
(2)
(2)
(2)
0
0
0
Cash Taxes Paid
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Cash Interest Paid
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Change in Working Capital
(0)
0
(0)
0
0
(0)
(0)
0
0
(0)
(0)
0
(1)
(1)
(1)
(1)
(1)
1
2
2
3
1
1
1
1
1
1
(0)
(1)
(1)
(1)
0
0
0
Cash from Operating Activities
(1)
N/A
(1)
+25%
(1)
+11%
(1)
-9%
(1)
+30%
(1)
-62%
(1)
-31%
(2)
-23%
(2)
-11%
(2)
+8%
(2)
-18%
(4)
-89%
(7)
-80%
(10)
-46%
(11)
-11%
(10)
+4%
(8)
+24%
(4)
+48%
(3)
+23%
(2)
+28%
(3)
-29%
(4)
-39%
(4)
+10%
(3)
+5%
(3)
+26%
(2)
+30%
(2)
+11%
(3)
-66%
(3)
-2%
(3)
-7%
(3)
0%
(1)
+55%
(1)
+11%
(1)
-10%
Investing Cash Flow
Capital Expenditures
(0)
(0)
(0)
0
0
0
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
0
(0)
(0)
(0)
0
Other Items
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
2
0
0
0
0
0
Cash from Investing Activities
(0)
N/A
0
N/A
(0)
N/A
0
N/A
0
N/A
0
N/A
0
-5%
0
-38%
0
-2%
(0)
N/A
(0)
-3%
(0)
+5%
(0)
-32%
(0)
+6%
(0)
-17%
(0)
-27%
(0)
+11%
(0)
-27%
(0)
-12%
(0)
+40%
(0)
-37%
(0)
+15%
(0)
+29%
(0)
-19%
(0)
+42%
(0)
+30%
(0)
-33%
2
N/A
2
+0%
0
N/A
2
N/A
0
-93%
0
-4%
0
N/A
Financing Cash Flow
Net Issuance of Common Stock
1
0
0
0
0
1
1
1
1
2
1
10
13
11
14
7
5
4
2
0
2
2
2
3
1
1
1
0
1
1
1
1
1
1
Other
0
0
0
0
0
0
0
0
0
0
2
2
0
2
(0)
(0)
(0)
(0)
(0)
(0)
0
0
(0)
(0)
0
0
(0)
0
0
0
0
0
0
0
Cash from Financing Activities
1
N/A
0
N/A
0
N/A
0
+3%
0
+21%
1
+105%
1
-24%
1
-1%
1
-11%
2
+199%
3
+64%
12
+268%
13
+8%
11
-14%
12
+8%
5
-54%
4
-20%
4
+1%
2
-51%
(0)
N/A
2
N/A
2
+5%
2
-1%
3
+45%
1
-57%
1
-8%
2
+23%
1
-64%
1
+66%
1
+0%
1
-29%
1
-1%
1
-7%
1
+66%
Change in Cash
Effect of Foreign Exchange Rates
(0)
0
0
0
0
0
0
0
0
(0)
0
0
0
0
0
(0)
(0)
(0)
(0)
0
(0)
0
0
0
0
(0)
(0)
0
(0)
0
0
(0)
0
(0)
Net Change in Cash
(0)
N/A
(1)
-343%
(0)
+51%
(0)
+18%
(0)
+62%
0
N/A
(0)
N/A
(1)
-85%
(1)
-33%
0
N/A
1
+425%
8
+591%
6
-25%
1
-82%
1
-20%
(5)
N/A
(4)
+27%
0
N/A
(1)
N/A
(2)
-96%
(1)
+58%
(2)
-100%
(2)
+21%
(0)
+72%
(1)
-193%
(1)
+52%
(0)
+77%
0
N/A
0
+169%
0
-40%
0
-94%
(1)
N/A
(0)
+19%
(0)
+65%
Free Cash Flow
Free Cash Flow
(1)
N/A
(1)
+28%
(1)
+9%
(1)
+10%
(1)
+20%
(1)
-62%
(1)
-32%
(2)
-27%
(2)
-11%
(2)
+7%
(2)
-18%
(4)
-85%
(7)
-79%
(10)
-45%
(11)
-11%
(10)
+4%
(8)
+23%
(4)
+47%
(3)
+22%
(2)
+29%
(3)
-29%
(4)
-37%
(4)
+11%
(4)
+5%
(3)
+27%
(2)
+30%
(2)
+10%
(3)
-64%
(3)
-3%
(3)
-4%
(3)
-3%
(1)
+55%
(1)
+12%
(1)
-7%
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett